Threats in bioterrorism. II: CDC category B and C agents (Q34743497)

4 August 2017

1 reference

title

Threats in bioterrorism. II: CDC category B and C agents (English)

1 reference

4 August 2017

0 references

Gregory J Moran

1

1 reference

4 August 2017

language of work or name

1 reference

1 May 2002

1 reference

Emergency medicine clinics of North America

4 August 2017

published in

1 reference

4 August 2017

volume

20

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

311-330

1 reference

Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

The chest film findings in 'Q' fever--a series of 35 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

1 reference

7 January 2021

Clinical recognition and management of patients exposed to biological warfare agents

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

An overview of human brucellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Misidentification of Brucella species with use of rapid bacterial identification systems

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Glanders in a military research microbiologist

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Biological warfare in the twentieth century: lessons from the past, challenges for the future.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Clinical and neuroradiographic manifestations of eastern equine encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Complex-specific immunoglobulin M antibody patterns in humans infected with alphaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Castor bean intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Quantification of ricin toxin using a highly sensitive avidin/biotin enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Escherichia coli O157:H7

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Laboratory diagnosis of Nipah and Hendra virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Treatment of acute Nipah encephalitis with ribavirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Evaluation of two commercially available immunoassays for the detection of hantavirus antibodies in serum samples

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Hantavirus Pulmonary Syndrome in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

Management of tuberculosis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8627%2801%2900003-7

7 January 2021

10.1016/S0733-8627(01)00003-7

Identifiers

DOI

1 reference

4 August 2017

1 reference